| 0 |
DRUG INEFFECTIVE |
178 |
| 1 |
NO ADVERSE EVENT |
120 |
| 2 |
APPLICATION SITE BURN |
57 |
| 3 |
PAIN |
44 |
| 4 |
APPLICATION SITE PAIN |
40 |
| 5 |
BLISTER |
33 |
| 6 |
BURNING SENSATION |
28 |
| 7 |
APPLICATION SITE ERYTHEMA |
24 |
| 8 |
SKIN BURNING SENSATION |
24 |
| 9 |
ARTHRALGIA |
23 |
| 10 |
APPLICATION SITE VESICLES |
22 |
| 11 |
PAIN IN EXTREMITY |
21 |
| 12 |
THERMAL BURN |
21 |
| 13 |
BURNS SECOND DEGREE |
20 |
| 14 |
ERYTHEMA |
20 |
| 15 |
FATIGUE |
19 |
| 16 |
HEADACHE |
19 |
| 17 |
NAUSEA |
19 |
| 18 |
CHEMICAL INJURY |
18 |
| 19 |
DYSPNOEA |
18 |
| 20 |
DIARRHOEA |
17 |
| 21 |
PRURITUS |
16 |
| 22 |
BACK PAIN |
15 |
| 23 |
SKIN EXFOLIATION |
14 |
| 24 |
VOMITING |
14 |
| 25 |
CHEMICAL BURN |
13 |
| 26 |
DIZZINESS |
13 |
| 27 |
HYPERSENSITIVITY |
13 |
| 28 |
INSOMNIA |
13 |
| 29 |
FALL |
12 |
| 30 |
PERIPHERAL SWELLING |
12 |
| 31 |
MUSCLE SPASMS |
11 |
| 32 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
11 |
| 33 |
PRODUCT USE ISSUE |
11 |
| 34 |
SCAR |
11 |
| 35 |
CONSTIPATION |
10 |
| 36 |
GAIT DISTURBANCE |
10 |
| 37 |
HYPOAESTHESIA |
10 |
| 38 |
INFUSION SITE PAIN |
10 |
| 39 |
LOSS OF CONSCIOUSNESS |
10 |
| 40 |
NECK PAIN |
10 |
| 41 |
PRODUCT QUALITY ISSUE |
10 |
| 42 |
RASH |
10 |
| 43 |
SCAB |
10 |
| 44 |
SKIN DISCOLOURATION |
9 |
| 45 |
URINARY TRACT INFECTION |
9 |
| 46 |
ARTHRITIS |
8 |
| 47 |
BURNS THIRD DEGREE |
8 |
| 48 |
DECREASED APPETITE |
8 |
| 49 |
MALAISE |
8 |
| 50 |
OFF LABEL USE |
8 |
| 51 |
PYREXIA |
8 |
| 52 |
ABDOMINAL PAIN |
7 |
| 53 |
ASTHENIA |
7 |
| 54 |
DEATH |
7 |
| 55 |
FEELING ABNORMAL |
7 |
| 56 |
SWELLING |
7 |
| 57 |
WEIGHT INCREASED |
7 |
| 58 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
6 |
| 59 |
HYPOTENSION |
6 |
| 60 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
6 |
| 61 |
INFECTION |
6 |
| 62 |
INFUSION SITE ERYTHEMA |
6 |
| 63 |
MUSCULOSKELETAL PAIN |
6 |
| 64 |
MYALGIA |
6 |
| 65 |
PNEUMONIA |
6 |
| 66 |
SOMNOLENCE |
6 |
| 67 |
ABDOMINAL DISCOMFORT |
5 |
| 68 |
ANAPHYLACTIC REACTION |
5 |
| 69 |
APPLICATION SITE DISCOLOURATION |
5 |
| 70 |
BLOOD PRESSURE DECREASED |
5 |
| 71 |
CHEMICAL BURN OF SKIN |
5 |
| 72 |
CONDITION AGGRAVATED |
5 |
| 73 |
CONTUSION |
5 |
| 74 |
DISCOMFORT |
5 |
| 75 |
EXPIRED PRODUCT ADMINISTERED |
5 |
| 76 |
FEELING HOT |
5 |
| 77 |
HYPERAESTHESIA |
5 |
| 78 |
LIMB DISCOMFORT |
5 |
| 79 |
OEDEMA PERIPHERAL |
5 |
| 80 |
PRODUCT USE IN UNAPPROVED INDICATION |
5 |
| 81 |
SKIN DISORDER |
5 |
| 82 |
SKIN IRRITATION |
5 |
| 83 |
URTICARIA |
5 |
| 84 |
AMNESIA |
4 |
| 85 |
ANXIETY |
4 |
| 86 |
APPLICATION SITE EXFOLIATION |
4 |
| 87 |
APPLICATION SITE PRURITUS |
4 |
| 88 |
APPLICATION SITE REACTION |
4 |
| 89 |
APPLICATION SITE SWELLING |
4 |
| 90 |
BLOOD PRESSURE INCREASED |
4 |
| 91 |
BRONCHITIS |
4 |
| 92 |
COUGH |
4 |
| 93 |
COVID-19 |
4 |
| 94 |
DEPRESSION |
4 |
| 95 |
DEVICE ISSUE |
4 |
| 96 |
DYSPHONIA |
4 |
| 97 |
EYE PAIN |
4 |
| 98 |
INFUSION SITE HAEMORRHAGE |
4 |
| 99 |
INFUSION SITE PRURITUS |
4 |
| 100 |
INFUSION SITE SWELLING |
4 |
| 101 |
INJURY |
4 |
| 102 |
JOINT SWELLING |
4 |
| 103 |
MOBILITY DECREASED |
4 |
| 104 |
MUSCULOSKELETAL STIFFNESS |
4 |
| 105 |
NASAL CONGESTION |
4 |
| 106 |
NASOPHARYNGITIS |
4 |
| 107 |
NERVE INJURY |
4 |
| 108 |
NEUROPATHY PERIPHERAL |
4 |
| 109 |
PAIN OF SKIN |
4 |
| 110 |
PARAESTHESIA |
4 |
| 111 |
PRODUCT ADHESION ISSUE |
4 |
| 112 |
PSORIASIS |
4 |
| 113 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
4 |
| 114 |
WOUND SECRETION |
4 |
| 115 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
4 |
| 116 |
APPLICATION SITE IRRITATION |
3 |
| 117 |
APPLICATION SITE SCAR |
3 |
| 118 |
ASTHMA |
3 |
| 119 |
BONE PAIN |
3 |
| 120 |
BURN INFECTION |
3 |
| 121 |
CARDIAC DISORDER |
3 |
| 122 |
CHEST DISCOMFORT |
3 |
| 123 |
CHEST PAIN |
3 |
| 124 |
CHILLS |
3 |
| 125 |
DEEP VEIN THROMBOSIS |
3 |
| 126 |
DEPRESSED MOOD |
3 |
| 127 |
DEVICE OCCLUSION |
3 |
| 128 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
3 |
| 129 |
DRUG DEPENDENCE |
3 |
| 130 |
DRUG EFFECT LESS THAN EXPECTED |
3 |
| 131 |
DYSGEUSIA |
3 |
| 132 |
EYE SWELLING |
3 |
| 133 |
FLUID RETENTION |
3 |
| 134 |
HEAD INJURY |
3 |
| 135 |
ILLNESS |
3 |
| 136 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
3 |
| 137 |
INCORRECT DRUG ADMINISTRATION DURATION |
3 |
| 138 |
INJECTION SITE BRUISING |
3 |
| 139 |
INJECTION SITE HAEMORRHAGE |
3 |
| 140 |
INJECTION SITE PAIN |
3 |
| 141 |
INTENTIONAL PRODUCT MISUSE |
3 |
| 142 |
JOINT STIFFNESS |
3 |
| 143 |
MEMORY IMPAIRMENT |
3 |
| 144 |
MUSCULAR WEAKNESS |
3 |
| 145 |
MUSCULOSKELETAL DISCOMFORT |
3 |
| 146 |
MYOCARDIAL INFARCTION |
3 |
| 147 |
MYOSITIS |
3 |
| 148 |
NEOPLASM MALIGNANT |
3 |
| 149 |
PRODUCT ODOUR ABNORMAL |
3 |
| 150 |
PRODUCTIVE COUGH |
3 |
| 151 |
RHEUMATOID ARTHRITIS |
3 |
| 152 |
ROAD TRAFFIC ACCIDENT |
3 |
| 153 |
SEPSIS |
3 |
| 154 |
THERAPEUTIC RESPONSE DECREASED |
3 |
| 155 |
TREMOR |
3 |
| 156 |
VISION BLURRED |
3 |
| 157 |
WEIGHT DECREASED |
3 |
| 158 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
3 |
| 159 |
ABDOMINAL PAIN UPPER |
2 |
| 160 |
ACCIDENT |
2 |
| 161 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
| 162 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
2 |
| 163 |
ADVERSE DRUG REACTION |
2 |
| 164 |
ADVERSE EVENT |
2 |
| 165 |
ALOPECIA |
2 |
| 166 |
APPLICATION SITE BRUISE |
2 |
| 167 |
APPLICATION SITE HYPERSENSITIVITY |
2 |
| 168 |
APPLICATION SITE RASH |
2 |
| 169 |
APPLICATION SITE SCAB |
2 |
| 170 |
ARTHROPATHY |
2 |
| 171 |
ASPIRATION |
2 |
| 172 |
BACK DISORDER |
2 |
| 173 |
BACK INJURY |
2 |
| 174 |
BACTERIAL TEST POSITIVE |
2 |
| 175 |
BLOOD PRESSURE ABNORMAL |
2 |
| 176 |
BURNS FIRST DEGREE |
2 |
| 177 |
CANDIDA INFECTION |
2 |
| 178 |
CARDIAC FAILURE CONGESTIVE |
2 |
| 179 |
CELLULITIS |
2 |
| 180 |
CHOKING |
2 |
| 181 |
CHONDROPATHY |
2 |
| 182 |
CHRONIC KIDNEY DISEASE |
2 |
| 183 |
CONFUSIONAL STATE |
2 |
| 184 |
DEVICE DISLOCATION |
2 |
| 185 |
DEVICE MAINTENANCE ISSUE |
2 |
| 186 |
DRUG DOSE OMISSION |
2 |
| 187 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
| 188 |
DRUG INTERACTION |
2 |
| 189 |
DRY MOUTH |
2 |
| 190 |
FLATULENCE |
2 |
| 191 |
FRUSTRATION TOLERANCE DECREASED |
2 |
| 192 |
GASTRITIS EROSIVE |
2 |
| 193 |
GINGIVITIS |
2 |
| 194 |
HAEMOPTYSIS |
2 |
| 195 |
HAEMORRHAGE |
2 |
| 196 |
HEART RATE INCREASED |
2 |
| 197 |
HERPES ZOSTER |
2 |
| 198 |
HOSPITALISATION |
2 |
| 199 |
HYPERTHYROIDISM |
2 |
| 200 |
IMPAIRED HEALING |
2 |
| 201 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
2 |
| 202 |
INFLAMMATION |
2 |
| 203 |
INFUSION SITE DISCOMFORT |
2 |
| 204 |
INFUSION SITE INFLAMMATION |
2 |
| 205 |
INFUSION SITE IRRITATION |
2 |
| 206 |
INJECTION SITE ERYTHEMA |
2 |
| 207 |
INSURANCE ISSUE |
2 |
| 208 |
INTERNATIONAL NORMALISED RATIO DECREASED |
2 |
| 209 |
JOINT EFFUSION |
2 |
| 210 |
LIMB INJURY |
2 |
| 211 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
| 212 |
LUNG DISORDER |
2 |
| 213 |
MEDICATION ERROR |
2 |
| 214 |
METASTASES TO BONE |
2 |
| 215 |
MIGRAINE |
2 |
| 216 |
MOVEMENT DISORDER |
2 |
| 217 |
MUSCLE ATROPHY |
2 |
| 218 |
MUSCLE STRAIN |
2 |
| 219 |
NASAL OEDEMA |
2 |
| 220 |
NEPHROPATHY |
2 |
| 221 |
NEURALGIA |
2 |
| 222 |
OEDEMA |
2 |
| 223 |
ORTHOSTATIC HYPOTENSION |
2 |
| 224 |
PALPITATIONS |
2 |
| 225 |
PRODUCT DOSE OMISSION |
2 |
| 226 |
PRODUCT DOSE OMISSION ISSUE |
2 |
| 227 |
PRODUCT PHYSICAL ISSUE |
2 |
| 228 |
PULMONARY EMBOLISM |
2 |
| 229 |
RASH ERYTHEMATOUS |
2 |
| 230 |
RASH PAPULAR |
2 |
| 231 |
RENAL IMPAIRMENT |
2 |
| 232 |
RHINORRHOEA |
2 |
| 233 |
SEASONAL ALLERGY |
2 |
| 234 |
SECOND DEGREE CHEMICAL BURN OF SKIN |
2 |
| 235 |
SEIZURE |
2 |
| 236 |
SINUSITIS |
2 |
| 237 |
SKIN DEPIGMENTATION |
2 |
| 238 |
SPEECH DISORDER |
2 |
| 239 |
SUSPECTED PRODUCT QUALITY ISSUE |
2 |
| 240 |
TACHYCARDIA |
2 |
| 241 |
TENDERNESS |
2 |
| 242 |
TERMINAL STATE |
2 |
| 243 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
| 244 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
| 245 |
THERAPY CESSATION |
2 |
| 246 |
THERAPY CHANGE |
2 |
| 247 |
THERAPY NON-RESPONDER |
2 |
| 248 |
TOOTH FRACTURE |
2 |
| 249 |
TOXICITY TO VARIOUS AGENTS |
2 |
| 250 |
UNDERDOSE |
2 |
| 251 |
URINARY RETENTION |
2 |
| 252 |
WOUND |
2 |
| 253 |
WRONG PRODUCT ADMINISTERED |
2 |
| 254 |
ABASIA |
1 |
| 255 |
ABDOMINAL DISTENSION |
1 |
| 256 |
ABNORMAL BEHAVIOUR |
1 |
| 257 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
1 |
| 258 |
ADMINISTRATION SITE PAIN |
1 |
| 259 |
ADULT FAILURE TO THRIVE |
1 |
| 260 |
ALLERGY TO PLANTS |
1 |
| 261 |
ALVEOLAR OSTEITIS |
1 |
| 262 |
ANKLE FRACTURE |
1 |
| 263 |
APPLICATION SITE DRYNESS |
1 |
| 264 |
APPLICATION SITE HAEMORRHAGE |
1 |
| 265 |
APPLICATION SITE HYPOAESTHESIA |
1 |
| 266 |
APPLICATION SITE INFECTION |
1 |
| 267 |
APPLICATION SITE INFLAMMATION |
1 |
| 268 |
APPLICATION SITE PUSTULES |
1 |
| 269 |
APPLICATION SITE WARMTH |
1 |
| 270 |
ASTHMATIC CRISIS |
1 |
| 271 |
ATRIAL FIBRILLATION |
1 |
| 272 |
ATRIOVENTRICULAR BLOCK |
1 |
| 273 |
BACTERIAL ABDOMINAL INFECTION |
1 |
| 274 |
BALANCE DISORDER |
1 |
| 275 |
BASAL GANGLIA HAEMATOMA |
1 |
| 276 |
BEDRIDDEN |
1 |
| 277 |
BILE DUCT STONE |
1 |
| 278 |
BLADDER ULCER |
1 |
| 279 |
BLINDNESS TRANSIENT |
1 |
| 280 |
BLOOD BLISTER |
1 |
| 281 |
BLOOD COUNT ABNORMAL |
1 |
| 282 |
BLOOD IRON INCREASED |
1 |
| 283 |
BLOOD PHOSPHORUS DECREASED |
1 |
| 284 |
BLOOD POTASSIUM DECREASED |
1 |
| 285 |
BLOOD PRESSURE FLUCTUATION |
1 |
| 286 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
| 287 |
BRADYCARDIA |
1 |
| 288 |
BREAST SWELLING |
1 |
| 289 |
BUNDLE BRANCH BLOCK RIGHT |
1 |
| 290 |
BURNS FOURTH DEGREE |
1 |
| 291 |
CARTILAGE INJURY |
1 |
| 292 |
CATARACT |
1 |
| 293 |
CEREBRAL ARTERIOSCLEROSIS |
1 |
| 294 |
CEREBRAL HAEMORRHAGE |
1 |
| 295 |
CEREBROVASCULAR ACCIDENT |
1 |
| 296 |
CHEST X-RAY ABNORMAL |
1 |
| 297 |
CHOLANGITIS |
1 |
| 298 |
CHONDROLYSIS |
1 |
| 299 |
CHROMATURIA |
1 |
| 300 |
CIRCULATORY COLLAPSE |
1 |
| 301 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
| 302 |
COAGULOPATHY |
1 |
| 303 |
COGNITIVE DISORDER |
1 |
| 304 |
COMPRESSION FRACTURE |
1 |
| 305 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
| 306 |
CONJUNCTIVITIS |
1 |
| 307 |
CRYING |
1 |
| 308 |
CYANOSIS |
1 |
| 309 |
CYSTITIS |
1 |
| 310 |
CYSTITIS INTERSTITIAL |
1 |
| 311 |
DEAFNESS |
1 |
| 312 |
DECREASED ACTIVITY |
1 |
| 313 |
DENTAL CARIES |
1 |
| 314 |
DERMATITIS |
1 |
| 315 |
DERMATITIS ACNEIFORM |
1 |
| 316 |
DERMATITIS CONTACT |
1 |
| 317 |
DEVICE ADHESION ISSUE |
1 |
| 318 |
DEVICE ALARM ISSUE |
1 |
| 319 |
DEVICE DIFFICULT TO USE |
1 |
| 320 |
DEVICE FAILURE |
1 |
| 321 |
DEVICE INFORMATION OUTPUT ISSUE |
1 |
| 322 |
DEVICE INFUSION ISSUE |
1 |
| 323 |
DEVICE POWER SOURCE ISSUE |
1 |
| 324 |
DEVICE STIMULATION ISSUE |
1 |
| 325 |
DISABILITY |
1 |
| 326 |
DISEASE PROGRESSION |
1 |
| 327 |
DISORIENTATION |
1 |
| 328 |
DRUG EFFECT INCOMPLETE |
1 |
| 329 |
DRUG HYPERSENSITIVITY |
1 |
| 330 |
DRUG SCREEN NEGATIVE |
1 |
| 331 |
DRUG TOLERANCE DECREASED |
1 |
| 332 |
DRUG TOXICITY |
1 |
| 333 |
DRUG WITHDRAWAL SYNDROME |
1 |
| 334 |
DRY EYE |
1 |
| 335 |
DRY SKIN |
1 |
| 336 |
DUST ALLERGY |
1 |
| 337 |
DYSPEPSIA |
1 |
| 338 |
DYSPHAGIA |
1 |
| 339 |
DYSPNOEA EXERTIONAL |
1 |
| 340 |
DYSTONIA |
1 |
| 341 |
EAR PAIN |
1 |
| 342 |
ECONOMIC PROBLEM |
1 |
| 343 |
ECZEMA |
1 |
| 344 |
EMOTIONAL DISTRESS |
1 |
| 345 |
ENTEROCOLITIS |
1 |
| 346 |
ENURESIS |
1 |
| 347 |
EPILEPSY |
1 |
| 348 |
EPISTAXIS |
1 |
| 349 |
ESCHAR |
1 |
| 350 |
ESSENTIAL HYPERTENSION |
1 |
| 351 |
EXPIRED DRUG ADMINISTERED |
1 |
| 352 |
EXPOSURE DURING PREGNANCY |
1 |
| 353 |
EYE DISORDER |
1 |
| 354 |
EYE INFLAMMATION |
1 |
| 355 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
| 356 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
| 357 |
FINGER DEFORMITY |
1 |
| 358 |
FROSTBITE |
1 |
| 359 |
FRUSTRATION |
1 |
| 360 |
GAIT INABILITY |
1 |
| 361 |
GALLBLADDER DISORDER |
1 |
| 362 |
GASTRIC ULCER |
1 |
| 363 |
GASTROINTESTINAL DISORDER |
1 |
| 364 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
| 365 |
GENITAL BURNING SENSATION |
1 |
| 366 |
GINGIVAL DISCOMFORT |
1 |
| 367 |
GINGIVAL SWELLING |
1 |
| 368 |
GLOMERULAR FILTRATION RATE INCREASED |
1 |
| 369 |
GLOSSITIS |
1 |
| 370 |
GLOSSODYNIA |
1 |
| 371 |
HAEMARTHROSIS |
1 |
| 372 |
HAEMATOCHEZIA |
1 |
| 373 |
HAEMORRHAGE INTRACRANIAL |
1 |
| 374 |
HAEMORRHAGIC ANAEMIA |
1 |
| 375 |
HALLUCINATION |
1 |
| 376 |
HEAD DISCOMFORT |
1 |
| 377 |
HEMIPARESIS |
1 |
| 378 |
HEPATOMEGALY |
1 |
| 379 |
HIATUS HERNIA |
1 |
| 380 |
HOT FLUSH |
1 |
| 381 |
HYDROTHORAX |
1 |
| 382 |
HYPERCALCAEMIA |
1 |
| 383 |
HYPERHIDROSIS |
1 |
| 384 |
HYPERKERATOSIS |
1 |
| 385 |
HYPERSOMNIA |
1 |
| 386 |
HYPERTENSIVE EMERGENCY |
1 |
| 387 |
HYPERTRIGLYCERIDAEMIA |
1 |
| 388 |
HYPERVIGILANCE |
1 |
| 389 |
HYPERVOLAEMIA |
1 |
| 390 |
HYPOACUSIS |
1 |
| 391 |
HYPOKALAEMIA |
1 |
| 392 |
HYPOTHERMIA |
1 |
| 393 |
INABILITY TO AFFORD MEDICATION |
1 |
| 394 |
INADEQUATE ANALGESIA |
1 |
| 395 |
INCISION SITE HAEMORRHAGE |
1 |
| 396 |
INCORRECT DOSE ADMINISTERED |
1 |
| 397 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
| 398 |
INCREASED APPETITE |
1 |
| 399 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
| 400 |
INFLUENZA A VIRUS TEST POSITIVE |
1 |
| 401 |
INFLUENZA LIKE ILLNESS |
1 |
| 402 |
INFUSION SITE INDURATION |
1 |
| 403 |
INFUSION SITE OEDEMA |
1 |
| 404 |
INFUSION SITE REACTION |
1 |
| 405 |
INFUSION SITE WARMTH |
1 |
| 406 |
INITIAL INSOMNIA |
1 |
| 407 |
INJECTION SITE INDURATION |
1 |
| 408 |
INJECTION SITE MASS |
1 |
| 409 |
INJECTION SITE OEDEMA |
1 |
| 410 |
INJECTION SITE SWELLING |
1 |
| 411 |
INJECTION SITE URTICARIA |
1 |
| 412 |
INTENTIONAL DOSE OMISSION |
1 |
| 413 |
INTENTIONAL OVERDOSE |
1 |
| 414 |
INTENTIONAL PRODUCT MISUSE TO CHILD |
1 |
| 415 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
| 416 |
IRRITABILITY |
1 |
| 417 |
JAUNDICE NEONATAL |
1 |
| 418 |
JOINT NOISE |
1 |
| 419 |
KELOID SCAR |
1 |
| 420 |
KNEE DEFORMITY |
1 |
| 421 |
LEG AMPUTATION |
1 |
| 422 |
LETHARGY |
1 |
| 423 |
LIMB CRUSHING INJURY |
1 |
| 424 |
LIMB MASS |
1 |
| 425 |
LIP SWELLING |
1 |
| 426 |
LOCAL SWELLING |
1 |
| 427 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
| 428 |
LOWER LIMB FRACTURE |
1 |
| 429 |
LUMBAR SPINAL STENOSIS |
1 |
| 430 |
LYMPHADENOPATHY |
1 |
| 431 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
| 432 |
MASS |
1 |
| 433 |
MASTOID EFFUSION |
1 |
| 434 |
MATERNAL DRUGS AFFECTING FOETUS |
1 |
| 435 |
MEDICAL DEVICE SITE PAIN |
1 |
| 436 |
MIDDLE INSOMNIA |
1 |
| 437 |
MOTOR DYSFUNCTION |
1 |
| 438 |
MUCOSAL HYPERTROPHY |
1 |
| 439 |
MULTI-ORGAN DISORDER |
1 |
| 440 |
MULTIPLE INJURIES |
1 |
| 441 |
MULTIPLE SCLEROSIS |
1 |
| 442 |
MUSCLE DISORDER |
1 |
| 443 |
MUSCLE HAEMORRHAGE |
1 |
| 444 |
MUSCLE RIGIDITY |
1 |
| 445 |
MUSCLE TIGHTNESS |
1 |
| 446 |
MUSCULOSKELETAL CHEST PAIN |
1 |
| 447 |
NECK SURGERY |
1 |
| 448 |
NEGATIVISM |
1 |
| 449 |
NEOPLASM |
1 |
| 450 |
NEPHROLITHIASIS |
1 |
| 451 |
NERVE COMPRESSION |
1 |
| 452 |
NEUTROPHIL COUNT ABNORMAL |
1 |
| 453 |
NIGHT SWEATS |
1 |
| 454 |
NIPPLE SWELLING |
1 |
| 455 |
NODULE |
1 |
| 456 |
OCULAR HYPERAEMIA |
1 |
| 457 |
OFF LABEL USE OF DEVICE |
1 |
| 458 |
ORCHIDECTOMY |
1 |
| 459 |
OROPHARYNGEAL PAIN |
1 |
| 460 |
OSTEOMYELITIS |
1 |
| 461 |
OSTEOPOROSIS |
1 |
| 462 |
PAIN IN JAW |
1 |
| 463 |
PANCREATIC MASS |
1 |
| 464 |
PANCREATITIS |
1 |
| 465 |
PANIC ATTACK |
1 |
| 466 |
PANIC REACTION |
1 |
| 467 |
PARANASAL SINUS HYPERSECRETION |
1 |
| 468 |
PELVIC PAIN |
1 |
| 469 |
PERICARDIAL EFFUSION |
1 |
| 470 |
PERICARDITIS |
1 |
| 471 |
PHARYNGEAL OEDEMA |
1 |
| 472 |
PHARYNGITIS STREPTOCOCCAL |
1 |
| 473 |
PLASMA CELL MYELOMA |
1 |
| 474 |
PLATELET COUNT ABNORMAL |
1 |
| 475 |
POISONING |
1 |
| 476 |
POLLAKIURIA |
1 |
| 477 |
POOR PERIPHERAL CIRCULATION |
1 |
| 478 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
| 479 |
POOR QUALITY SLEEP |
1 |
| 480 |
POST PROCEDURAL COMPLICATION |
1 |
| 481 |
POST PROCEDURAL INFECTION |
1 |
| 482 |
POST-ACUTE COVID-19 SYNDROME |
1 |
| 483 |
POST-TRAUMATIC NECK SYNDROME |
1 |
| 484 |
PRESCRIBED OVERDOSE |
1 |
| 485 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
| 486 |
PRODUCT CLOSURE ISSUE |
1 |
| 487 |
PRODUCT CONTAMINATION MICROBIAL |
1 |
| 488 |
PRODUCT LABEL ISSUE |
1 |
| 489 |
PRODUCT LABEL ON WRONG PRODUCT |
1 |
| 490 |
PRODUCT PACKAGE ASSOCIATED INJURY |
1 |
| 491 |
PRODUCT SOLUBILITY ABNORMAL |
1 |
| 492 |
PRODUCT SUBSTITUTION ISSUE |
1 |
| 493 |
PRODUCT TASTE ABNORMAL |
1 |
| 494 |
PROSTATE CANCER METASTATIC |
1 |
| 495 |
PSORIATIC ARTHROPATHY |
1 |
| 496 |
PULMONARY HYPERTENSION |
1 |
| 497 |
PULMONARY MASS |
1 |
| 498 |
PULMONARY PAIN |
1 |
| 499 |
QUALITY OF LIFE DECREASED |
1 |
| 500 |
RADICULOPATHY |
1 |
| 501 |
RASH MACULAR |
1 |
| 502 |
RASH MACULO-PAPULAR |
1 |
| 503 |
RASH PRURITIC |
1 |
| 504 |
RECALLED PRODUCT ADMINISTERED |
1 |
| 505 |
RENAL DISORDER |
1 |
| 506 |
RENAL FAILURE ACUTE |
1 |
| 507 |
RESPIRATORY DISORDER |
1 |
| 508 |
RESPIRATORY TRACT INFECTION |
1 |
| 509 |
RHABDOMYOLYSIS |
1 |
| 510 |
RHONCHI |
1 |
| 511 |
ROTATOR CUFF SYNDROME |
1 |
| 512 |
SCHIZOAFFECTIVE DISORDER |
1 |
| 513 |
SCOLIOSIS |
1 |
| 514 |
SENSITIVE SKIN |
1 |
| 515 |
SERUM FERRITIN DECREASED |
1 |
| 516 |
SHOULDER OPERATION |
1 |
| 517 |
SINGLE COMPONENT OF A TWO-COMPONENT PRODUCT ADMINISTERED |
1 |
| 518 |
SINUS DISORDER |
1 |
| 519 |
SKIN ABRASION |
1 |
| 520 |
SKIN GRAFT |
1 |
| 521 |
SKIN HAEMORRHAGE |
1 |
| 522 |
SKIN ODOUR ABNORMAL |
1 |
| 523 |
SKIN ULCER |
1 |
| 524 |
SKIN WARM |
1 |
| 525 |
SLEEP DEFICIT |
1 |
| 526 |
SLEEP DISORDER |
1 |
| 527 |
SPINAL DISORDER |
1 |
| 528 |
SQUAMOUS CELL CARCINOMA |
1 |
| 529 |
STENOSIS |
1 |
| 530 |
SURGERY |
1 |
| 531 |
SUSPECTED COVID-19 |
1 |
| 532 |
SWELLING FACE |
1 |
| 533 |
SWOLLEN TONGUE |
1 |
| 534 |
SYNCOPE |
1 |
| 535 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
| 536 |
TEMPOROMANDIBULAR JOINT SYNDROME |
1 |
| 537 |
TENDON DISORDER |
1 |
| 538 |
TENDON PAIN |
1 |
| 539 |
TENDONITIS |
1 |
| 540 |
THALAMUS HAEMORRHAGE |
1 |
| 541 |
THERAPY PARTIAL RESPONDER |
1 |
| 542 |
THIRD DEGREE CHEMICAL BURN OF SKIN |
1 |
| 543 |
THROMBOSIS |
1 |
| 544 |
TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED |
1 |
| 545 |
TOOTHACHE |
1 |
| 546 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
| 547 |
TRAUMATIC HAEMORRHAGE |
1 |
| 548 |
TRYPTASE INCREASED |
1 |
| 549 |
UNEVALUABLE EVENT |
1 |
| 550 |
UNINTENTIONAL USE FOR UNAPPROVED INDICATION |
1 |
| 551 |
URINARY INCONTINENCE |
1 |
| 552 |
URINE OUTPUT DECREASED |
1 |
| 553 |
VARICOSE VEIN |
1 |
| 554 |
VENTRICULAR SEPTAL DEFECT |
1 |
| 555 |
VERY LOW DENSITY LIPOPROTEIN INCREASED |
1 |
| 556 |
VISUAL IMPAIRMENT |
1 |
| 557 |
WHEELCHAIR USER |
1 |
| 558 |
WHEEZING |
1 |
| 559 |
WOUND HAEMORRHAGE |
1 |
| 560 |
WOUND INFECTION |
1 |